9-color and 10-color flow cytometry in the clinical laboratory.

CONTEXT The development of commercial flow cytometers capable of detecting more than 10 simultaneous fluorescent signals presents opportunities for improved diagnosis and monitoring of patients with leukemia and lymphoma. OBJECTIVE To describe instrument and reagent characteristics necessary for successful 9-color and 10-color flow cytometry in a clinical setting. DESIGN Systematic review of issues related to instrument settings, reagent performance, and general principles of panel construction. RESULTS Nine-color and 10-color flow cytometry offers the possibility for increased accuracy in population identification, the ability to obtain detailed information from paucicellular specimens, improved laboratory efficiency, and the means to consistently detect abnormal populations at low levels. Careful attention to details of instrument and reagent performance allows for the development of panels suitable for screening of samples for leukemia and lymphoma in a clinical setting. CONCLUSIONS The characteristics of this technique are particularly well suited to the analysis of leukemia and lymphoma and have the potential to revolutionize and standardize this type of analysis in the clinical laboratory.

[1]  Mario Roederer,et al.  Dear Reader, , 2003, Nature Medicine.

[2]  R. Braylan,et al.  Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasias , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[3]  R. Braylan,et al.  Flow cytometric analysis of lymphomas and lymphoproliferative disorders. , 2001, Seminars in hematology.

[4]  M Roederer,et al.  Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. , 2001, Cytometry.

[5]  S. Richards,et al.  Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. , 2000, Cytometry.

[6]  M. Roederer,et al.  A practical approach to multicolor flow cytometry for immunophenotyping. , 2000, Journal of immunological methods.

[7]  B. Wood,et al.  Using 4-color flow cytometry to identify abnormal myeloid populations. , 2003, Archives of pathology & laboratory medicine.

[8]  Francisco Ortuño,et al.  Immunophenotyping of acute leukemias and myelodysplastic syndromes , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[9]  P. Chattopadhyay,et al.  Seventeen-colour flow cytometry: unravelling the immune system , 2004, Nature Reviews Immunology.

[10]  B. Wood,et al.  Multicolor immunophenotyping: human immune system hematopoiesis. , 2004, Methods in cell biology.

[11]  M. Borowitz,et al.  U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry. Bethesda, Maryland, November 16-17, 1995. , 1997, Cytometry.

[12]  M. Borowitz,et al.  Flow cytometry in the diagnosis of acute leukemia. , 2001, Seminars in hematology.